Jeff Gaus

Since the HITECH Act in 2009 and the Affordable Care Act in 2010, there has been significant consolidation of provider organizations and the introduction of many new decision-makers and key influencers. Healthcare organizations are using the wealth of new data to determine how they achieve the triple aim – providing quality health care at a lower cost with high patient satisfaction.

Jennifer surveyed leading pharmaceutical, medical technology and solutions organizations to gain specific insight into how they are changing to meet the needs of the market. In this session, she shares her findings, observations and insights into how pharma can embrace the new reality. Attendees will learn how to:
• Evolve the individual roles to meet the needs of a collaborative selling environment
• Update their competencies, KPIs and other performance measures and processes
• Utilize tools and technology to both accelerate and sustain those changes.

• Make sense of big data and learn best practices for analysis
• Managing data for specialty pharma
• Overcome privacy hurdles while working with data
• Leverage insights for effective marketing and sales campaigns

In a perfect world, we’d all like to be a little more patient-centric and outcomes-focused. This panel brings together views from both pharma and a pharmacist/patient engagement expert to examine the impact of health disparities on health outcomes.
• Discuss how cultural competency will this impact the future of medicine in terms of pharmacogenomics and precision medicine
• Patient Education – are educational resources appropriate for target audiences?
• Healthcare provider empowerment – what tools and resources do healthcare professionals need to engage vulnerable patient populations?

• Provide channel marketing and sales force enablement insights for a customer-obsessed culture
• Reorganize your organization’s approach to the field